nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—Crohn's disease	0.111	0.167	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—Crohn's disease	0.0816	0.123	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—Crohn's disease	0.0791	0.119	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—Crohn's disease	0.0767	0.116	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—Crohn's disease	0.0687	0.104	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—Crohn's disease	0.067	0.101	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—Crohn's disease	0.0638	0.0961	CrCrCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—Crohn's disease	0.0633	0.878	CbGbCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—Crohn's disease	0.0596	0.0899	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—Crohn's disease	0.056	0.0844	CrCrCtD
Medroxyprogesterone Acetate—AR—scrotum—Crohn's disease	0.0151	0.272	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—Crohn's disease	0.00884	0.122	CbGbCtD
Medroxyprogesterone Acetate—AR—penis—Crohn's disease	0.00681	0.123	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—digestive system—Crohn's disease	0.004	0.0719	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—Crohn's disease	0.00228	0.0411	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—smooth muscle tissue—Crohn's disease	0.00214	0.0384	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—mammalian vulva—Crohn's disease	0.00192	0.0346	CbGeAlD
Medroxyprogesterone Acetate—PGR—epithelium—Crohn's disease	0.0015	0.027	CbGeAlD
Medroxyprogesterone Acetate—PGR—smooth muscle tissue—Crohn's disease	0.00145	0.026	CbGeAlD
Medroxyprogesterone Acetate—AR—epithelium—Crohn's disease	0.0012	0.0215	CbGeAlD
Medroxyprogesterone Acetate—ESR1—epithelium—Crohn's disease	0.00117	0.0211	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—Crohn's disease	0.00116	0.0208	CbGeAlD
Medroxyprogesterone Acetate—AR—smooth muscle tissue—Crohn's disease	0.00115	0.0207	CbGeAlD
Medroxyprogesterone Acetate—AR—skin of body—Crohn's disease	0.00114	0.0205	CbGeAlD
Medroxyprogesterone Acetate—ESR1—smooth muscle tissue—Crohn's disease	0.00113	0.0204	CbGeAlD
Medroxyprogesterone Acetate—AR—mammalian vulva—Crohn's disease	0.00104	0.0187	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—Crohn's disease	0.000963	0.0173	CbGeAlD
Medroxyprogesterone Acetate—AR—lymphoid tissue—Crohn's disease	0.000921	0.0166	CbGeAlD
Medroxyprogesterone Acetate—AR—digestive system—Crohn's disease	0.00091	0.0164	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—Crohn's disease	0.000904	0.0163	CbGeAlD
Medroxyprogesterone Acetate—ESR1—digestive system—Crohn's disease	0.000893	0.0161	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—epithelium—Crohn's disease	0.000866	0.0156	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—smooth muscle tissue—Crohn's disease	0.000834	0.015	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—skin of body—Crohn's disease	0.000824	0.0148	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—mammalian vulva—Crohn's disease	0.000751	0.0135	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—Crohn's disease	0.000667	0.012	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—digestive system—Crohn's disease	0.000659	0.0119	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—digestive system—Crohn's disease	0.000653	0.0118	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—Crohn's disease	0.000652	0.0117	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—Crohn's disease	0.00052	0.00935	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—Crohn's disease	0.00051	0.00918	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—digestive system—Crohn's disease	0.000498	0.00897	CbGeAlD
Medroxyprogesterone Acetate—Blood creatinine increased—Mesalazine—Crohn's disease	0.000435	0.00226	CcSEcCtD
Medroxyprogesterone Acetate—Necrosis—Prednisone—Crohn's disease	0.000431	0.00224	CcSEcCtD
Medroxyprogesterone Acetate—Abscess—Prednisone—Crohn's disease	0.000428	0.00222	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Mesalazine—Crohn's disease	0.000425	0.00221	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000424	0.0022	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Azathioprine—Crohn's disease	0.000422	0.0022	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Mercaptopurine—Crohn's disease	0.00042	0.00219	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Mesalazine—Crohn's disease	0.000419	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Mesalazine—Crohn's disease	0.000418	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—Glycosuria—Prednisone—Crohn's disease	0.000418	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Mesalazine—Crohn's disease	0.000415	0.00216	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000412	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000409	0.00213	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Mercaptopurine—Crohn's disease	0.000408	0.00212	CcSEcCtD
Medroxyprogesterone Acetate—Endocrine disorder—Prednisone—Crohn's disease	0.000408	0.00212	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Mesalazine—Crohn's disease	0.000404	0.0021	CcSEcCtD
Medroxyprogesterone Acetate—Acne—Prednisone—Crohn's disease	0.000402	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Mesalazine—Crohn's disease	0.000401	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Mesalazine—Crohn's disease	0.000401	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Mesalazine—Crohn's disease	0.000401	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Mercaptopurine—Crohn's disease	0.000401	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Bronchospasm—Mesalazine—Crohn's disease	0.000395	0.00205	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Azathioprine—Crohn's disease	0.000393	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Azathioprine—Crohn's disease	0.000393	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Mesalazine—Crohn's disease	0.000386	0.00201	CcSEcCtD
Medroxyprogesterone Acetate—Amenorrhoea—Prednisone—Crohn's disease	0.000385	0.002	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Mesalazine—Crohn's disease	0.000385	0.002	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000383	0.00199	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—lymph node—Crohn's disease	0.000376	0.00677	CbGeAlD
Medroxyprogesterone Acetate—Dysuria—Mesalazine—Crohn's disease	0.000375	0.00195	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000373	0.00194	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000371	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Mesalazine—Crohn's disease	0.000371	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Mercaptopurine—Crohn's disease	0.000365	0.0019	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Mesalazine—Crohn's disease	0.000365	0.0019	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Mesalazine—Crohn's disease	0.000363	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000363	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Leukocytosis—Prednisone—Crohn's disease	0.00036	0.00187	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Mesalazine—Crohn's disease	0.000358	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Mesalazine—Crohn's disease	0.000358	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Ulcer—Prednisone—Crohn's disease	0.000358	0.00186	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Mesalazine—Crohn's disease	0.000357	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Azathioprine—Crohn's disease	0.000354	0.00184	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Azathioprine—Crohn's disease	0.000353	0.00183	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000351	0.00182	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Mesalazine—Crohn's disease	0.000349	0.00181	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Mesalazine—Crohn's disease	0.000349	0.00181	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Mesalazine—Crohn's disease	0.000348	0.00181	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Mesalazine—Crohn's disease	0.000343	0.00178	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000338	0.00176	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Mesalazine—Crohn's disease	0.000337	0.00175	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Mesalazine—Crohn's disease	0.000336	0.00174	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Azathioprine—Crohn's disease	0.000333	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Mercaptopurine—Crohn's disease	0.000332	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Mesalazine—Crohn's disease	0.000323	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—Fluid retention—Prednisone—Crohn's disease	0.000321	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Mesalazine—Crohn's disease	0.000321	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Mesalazine—Crohn's disease	0.000321	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Mesalazine—Crohn's disease	0.000319	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Azathioprine—Crohn's disease	0.000318	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Azathioprine—Crohn's disease	0.000318	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Mesalazine—Crohn's disease	0.000317	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Mesalazine—Crohn's disease	0.000316	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Azathioprine—Crohn's disease	0.000316	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Mesalazine—Crohn's disease	0.000316	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Mesalazine—Crohn's disease	0.000315	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Azathioprine—Crohn's disease	0.000312	0.00162	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00031	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Mesalazine—Crohn's disease	0.000304	0.00158	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Mesalazine—Crohn's disease	0.0003	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Mesalazine—Crohn's disease	0.000299	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Mesalazine—Crohn's disease	0.000298	0.00155	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Prednisone—Crohn's disease	0.000294	0.00153	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Mesalazine—Crohn's disease	0.000291	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Euphoric mood—Prednisone—Crohn's disease	0.000291	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Mesalazine—Crohn's disease	0.00029	0.00151	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Mesalazine—Crohn's disease	0.000289	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Mesalazine—Crohn's disease	0.000288	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Mercaptopurine—Crohn's disease	0.000288	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Azathioprine—Crohn's disease	0.000285	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Mesalazine—Crohn's disease	0.000284	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Prednisone—Crohn's disease	0.000284	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Azathioprine—Crohn's disease	0.000284	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Diabetes mellitus—Prednisone—Crohn's disease	0.000282	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Mesalazine—Crohn's disease	0.000281	0.00146	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Mesalazine—Crohn's disease	0.00028	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Azathioprine—Crohn's disease	0.000277	0.00144	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Mesalazine—Crohn's disease	0.000275	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Mesalazine—Crohn's disease	0.000274	0.00143	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Mesalazine—Crohn's disease	0.000274	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Mesalazine—Crohn's disease	0.000271	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac failure congestive—Prednisone—Crohn's disease	0.000271	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Mesalazine—Crohn's disease	0.00027	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Mesalazine—Crohn's disease	0.000269	0.0014	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Mercaptopurine—Crohn's disease	0.000267	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Mercaptopurine—Crohn's disease	0.000265	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Mercaptopurine—Crohn's disease	0.000265	0.00138	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Mesalazine—Crohn's disease	0.000262	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Amnesia—Prednisone—Crohn's disease	0.000261	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Prednisone—Crohn's disease	0.000261	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Azathioprine—Crohn's disease	0.000261	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Azathioprine—Crohn's disease	0.000261	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000259	0.00135	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Mesalazine—Crohn's disease	0.000259	0.00135	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Mesalazine—Crohn's disease	0.000258	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Azathioprine—Crohn's disease	0.000258	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Mesalazine—Crohn's disease	0.000255	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Purpura—Prednisone—Crohn's disease	0.000255	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Mesalazine—Crohn's disease	0.000252	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Mesalazine—Crohn's disease	0.000251	0.00131	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Mesalazine—Crohn's disease	0.000251	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Mercaptopurine—Crohn's disease	0.00025	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—SLC22A4—Crohn's disease	0.000249	0.452	CrCbGaD
Medroxyprogesterone Acetate—Infection—Azathioprine—Crohn's disease	0.000249	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Mesalazine—Crohn's disease	0.000247	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Mesalazine—Crohn's disease	0.000246	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Prednisone—Crohn's disease	0.000246	0.00128	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Azathioprine—Crohn's disease	0.000245	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Azathioprine—Crohn's disease	0.000243	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Prednisone—Crohn's disease	0.000242	0.00126	CcSEcCtD
Medroxyprogesterone Acetate—Psychotic disorder—Prednisone—Crohn's disease	0.00024	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Mesalazine—Crohn's disease	0.000238	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Mesalazine—Crohn's disease	0.000238	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Mesalazine—Crohn's disease	0.000238	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Mesalazine—Crohn's disease	0.000237	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Prednisone—Crohn's disease	0.000237	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000236	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Mesalazine—Crohn's disease	0.000235	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Prednisone—Crohn's disease	0.000234	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Azathioprine—Crohn's disease	0.000234	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Mesalazine—Crohn's disease	0.000233	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Prednisone—Crohn's disease	0.000233	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Mesalazine—Crohn's disease	0.00023	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000228	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Mesalazine—Crohn's disease	0.000228	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Mesalazine—Crohn's disease	0.000228	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Mesalazine—Crohn's disease	0.000227	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Prednisone—Crohn's disease	0.000225	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Mesalazine—Crohn's disease	0.000224	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Mesalazine—Crohn's disease	0.000224	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Prednisone—Crohn's disease	0.000223	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Mesalazine—Crohn's disease	0.000223	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Mesalazine—Crohn's disease	0.000223	0.00116	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Mesalazine—Crohn's disease	0.000222	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Mesalazine—Crohn's disease	0.000221	0.00115	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Mesalazine—Crohn's disease	0.000217	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000217	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Prednisone—Crohn's disease	0.000217	0.00113	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000216	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Prednisone—Crohn's disease	0.000214	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Mesalazine—Crohn's disease	0.000213	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000208	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Sweating increased—Prednisone—Crohn's disease	0.000207	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Azathioprine—Crohn's disease	0.000206	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Mesalazine—Crohn's disease	0.000206	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Mesalazine—Crohn's disease	0.000205	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000205	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Mesalazine—Crohn's disease	0.000203	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Mesalazine—Crohn's disease	0.000203	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Mesalazine—Crohn's disease	0.000201	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Mesalazine—Crohn's disease	0.000198	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Azathioprine—Crohn's disease	0.000198	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Azathioprine—Crohn's disease	0.000198	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000197	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Mesalazine—Crohn's disease	0.000197	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Mesalazine—Crohn's disease	0.000195	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Prednisone—Crohn's disease	0.000193	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Prednisone—Crohn's disease	0.000192	0.000998	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Prednisone—Crohn's disease	0.000191	0.000995	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Prednisone—Crohn's disease	0.000189	0.000981	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Mesalazine—Crohn's disease	0.000188	0.000977	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Prednisone—Crohn's disease	0.000187	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000187	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Prednisone—Crohn's disease	0.000186	0.000964	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Prednisone—Crohn's disease	0.000186	0.000964	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Azathioprine—Crohn's disease	0.000185	0.000959	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Mesalazine—Crohn's disease	0.000181	0.000942	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Mesalazine—Crohn's disease	0.00018	0.000938	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Mesalazine—Crohn's disease	0.00018	0.000938	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Prednisone—Crohn's disease	0.000173	0.000899	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Azathioprine—Crohn's disease	0.000171	0.000891	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Prednisone—Crohn's disease	0.000171	0.000888	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Prednisone—Crohn's disease	0.00017	0.000883	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Mesalazine—Crohn's disease	0.000168	0.000874	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Prednisone—Crohn's disease	0.000167	0.000868	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Azathioprine—Crohn's disease	0.000166	0.000861	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Mesalazine—Crohn's disease	0.000164	0.000851	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Mesalazine—Crohn's disease	0.000161	0.000839	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—Crohn's disease	0.00016	0.291	CrCbGaD
Medroxyprogesterone Acetate—Vomiting—Azathioprine—Crohn's disease	0.000159	0.000828	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Prednisone—Crohn's disease	0.000159	0.000825	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Azathioprine—Crohn's disease	0.000158	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Azathioprine—Crohn's disease	0.000158	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Azathioprine—Crohn's disease	0.000157	0.000816	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Mesalazine—Crohn's disease	0.000156	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Prednisone—Crohn's disease	0.000154	0.000801	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Prednisone—Crohn's disease	0.000153	0.000798	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Mesalazine—Crohn's disease	0.000151	0.000784	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Prednisone—Crohn's disease	0.00015	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Prednisone—Crohn's disease	0.000149	0.000774	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Azathioprine—Crohn's disease	0.000149	0.000773	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisone—Crohn's disease	0.000148	0.000769	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Prednisone—Crohn's disease	0.000148	0.000769	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Cellular roles of Anthrax toxin—TNF—Crohn's disease	0.000147	0.00945	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear signaling by ERBB4—JAK2—Crohn's disease	0.000146	0.0094	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Mesalazine—Crohn's disease	0.000145	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Mesalazine—Crohn's disease	0.000144	0.000748	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Mesalazine—Crohn's disease	0.000144	0.000747	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000143	0.0092	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Mesalazine—Crohn's disease	0.000143	0.000743	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—Crohn's disease	0.000137	0.000713	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—Crohn's disease	0.000137	0.000711	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Prednisone—Crohn's disease	0.000136	0.000707	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Mesalazine—Crohn's disease	0.000136	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—Crohn's disease	0.000135	0.000703	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisone—Crohn's disease	0.000133	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisone—Crohn's disease	0.000133	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisone—Crohn's disease	0.000133	0.00069	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—Crohn's disease	0.00013	0.000676	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00013	0.00833	CbGpPWpGaD
Medroxyprogesterone Acetate—Convulsion—Prednisone—Crohn's disease	0.000128	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000126	0.00812	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—RBX1—Crohn's disease	0.000126	0.00811	CbGpPWpGaD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—Crohn's disease	0.000126	0.000655	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—Crohn's disease	0.000126	0.000655	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—Crohn's disease	0.000125	0.000652	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000125	0.00065	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Prednisone—Crohn's disease	0.000124	0.000647	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000122	0.00788	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000122	0.00783	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—Crohn's disease	0.000121	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisone—Crohn's disease	0.000121	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Prednisone—Crohn's disease	0.00012	0.000623	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Prednisone—Crohn's disease	0.000119	0.000617	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—Crohn's disease	0.000118	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—Crohn's disease	0.000118	0.000612	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—Crohn's disease	0.000117	0.00061	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—Crohn's disease	0.000117	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Prednisone—Crohn's disease	0.000115	0.000598	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PLA2G4F—Crohn's disease	0.00011	0.00711	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00011	0.000572	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—Crohn's disease	0.000109	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—Crohn's disease	0.000108	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—Crohn's disease	0.000106	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—Crohn's disease	0.000105	0.000546	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000104	0.0067	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Prednisone—Crohn's disease	0.000104	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	0.000104	0.00666	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Prednisone—Crohn's disease	0.000103	0.000537	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	9.97e-05	0.00642	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—Crohn's disease	9.95e-05	0.000517	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—Crohn's disease	9.87e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—JAK2—Crohn's disease	9.59e-05	0.00617	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Prednisone—Crohn's disease	9.59e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—Crohn's disease	9.54e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—Crohn's disease	9.54e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—MTMR3—Crohn's disease	9.39e-05	0.00604	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—SMAD3—Crohn's disease	9.25e-05	0.00595	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—CD4—Crohn's disease	9.09e-05	0.00585	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL10—Crohn's disease	8.97e-05	0.00577	CbGpPWpGaD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—Crohn's disease	8.95e-05	0.163	CrCbGaD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—Crohn's disease	8.89e-05	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—SMAD3—Crohn's disease	8.83e-05	0.00568	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL10—Crohn's disease	8.83e-05	0.00568	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Crohn's disease	8.8e-05	0.00566	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SMAD3—Crohn's disease	8.7e-05	0.0056	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Prednisone—Crohn's disease	8.66e-05	0.00045	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Nuclear signaling by ERBB4—JAK2—Crohn's disease	8.58e-05	0.00552	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Prednisone—Crohn's disease	8.54e-05	0.000444	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	8.48e-05	0.00546	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—Crohn's disease	8.26e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	8.25e-05	0.00531	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.11e-05	0.00522	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Prednisone—Crohn's disease	7.98e-05	0.000415	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	7.98e-05	0.00513	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	7.86e-05	0.00506	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	7.68e-05	0.00494	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Prednisone—Crohn's disease	7.67e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisone—Crohn's disease	7.61e-05	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—Crohn's disease	7.6e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.6e-05	0.00489	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	7.58e-05	0.00488	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	7.56e-05	0.00487	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Prednisone—Crohn's disease	7.56e-05	0.000393	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—RBX1—Crohn's disease	7.4e-05	0.00476	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—FADS1—Crohn's disease	7.31e-05	0.00471	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PTRF—Crohn's disease	7.3e-05	0.0047	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Prednisone—Crohn's disease	7.17e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	7.07e-05	0.00455	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—STAT3—Crohn's disease	7.04e-05	0.00453	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GPX4—Crohn's disease	6.85e-05	0.00441	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	6.85e-05	0.00441	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	6.63e-05	0.00427	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GCKR—Crohn's disease	6.61e-05	0.00426	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL10—Crohn's disease	6.13e-05	0.00395	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IFNG—Crohn's disease	6.05e-05	0.00389	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	6.01e-05	0.00387	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—SOCS1—Crohn's disease	6e-05	0.00386	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	5.84e-05	0.00376	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Crohn's disease	5.72e-05	0.00368	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RSPO3—Crohn's disease	5.69e-05	0.00366	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—CXCL8—Crohn's disease	5.62e-05	0.00362	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PTRF—Crohn's disease	5.56e-05	0.00358	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	5.49e-05	0.00353	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PLA2G4F—Crohn's disease	5.45e-05	0.00351	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—IFNG—Crohn's disease	5.4e-05	0.00347	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SEL1L—Crohn's disease	5.4e-05	0.00347	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IFNG—Crohn's disease	5.27e-05	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ACKR2—Crohn's disease	5.26e-05	0.00338	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IFNG—Crohn's disease	5.19e-05	0.00334	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—ALB—Crohn's disease	5.19e-05	0.0943	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—SMAD3—Crohn's disease	5.18e-05	0.00333	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—TYK2—Crohn's disease	5.16e-05	0.00332	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.11e-05	0.00329	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—JAK2—Crohn's disease	5.08e-05	0.00327	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MLN—Crohn's disease	4.99e-05	0.00321	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—JAK2—Crohn's disease	4.92e-05	0.00317	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CXCL8—Crohn's disease	4.9e-05	0.00315	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—LTF—Crohn's disease	4.84e-05	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CXCL8—Crohn's disease	4.83e-05	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	4.78e-05	0.00307	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.73e-05	0.00304	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL10—Crohn's disease	4.65e-05	0.00299	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MTMR3—Crohn's disease	4.64e-05	0.00298	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	4.58e-05	0.00294	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—UBE2D1—Crohn's disease	4.57e-05	0.00294	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TAGAP—Crohn's disease	4.56e-05	0.00293	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	4.46e-05	0.00287	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—IL1B—Crohn's disease	4.45e-05	0.00286	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ZFP36L1—Crohn's disease	4.37e-05	0.00281	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PTRF—Crohn's disease	4.28e-05	0.00276	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Crohn's disease	4.25e-05	0.00274	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—STAT3—Crohn's disease	4.22e-05	0.00272	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PTRF—Crohn's disease	4.22e-05	0.00272	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ACKR2—Crohn's disease	4.15e-05	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.14e-05	0.00266	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.02e-05	0.00259	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RSPO3—Crohn's disease	3.99e-05	0.00256	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MLN—Crohn's disease	3.93e-05	0.00253	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—GCKR—Crohn's disease	3.9e-05	0.00251	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SEL1L—Crohn's disease	3.78e-05	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—STAT3—Crohn's disease	3.73e-05	0.0024	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—DNMT3A—Crohn's disease	3.72e-05	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—FADS1—Crohn's disease	3.61e-05	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TAGAP—Crohn's disease	3.6e-05	0.00231	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—UBE2D1—Crohn's disease	3.49e-05	0.00224	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR9—Crohn's disease	3.46e-05	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SLC11A1—Crohn's disease	3.45e-05	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.44e-05	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GPX4—Crohn's disease	3.38e-05	0.00218	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.35e-05	0.00216	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ZFP36L1—Crohn's disease	3.33e-05	0.00214	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—SMAD3—Crohn's disease	3.27e-05	0.00211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.27e-05	0.0021	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GCKR—Crohn's disease	3.27e-05	0.0021	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.22e-05	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GPR65—Crohn's disease	3.21e-05	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—Crohn's disease	3.16e-05	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RSPO3—Crohn's disease	3.14e-05	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—TYK2—Crohn's disease	3.03e-05	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SEL1L—Crohn's disease	2.98e-05	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RBX1—Crohn's disease	2.96e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HSPA1B—Crohn's disease	2.96e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	2.94e-05	0.00189	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.94e-05	0.00189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.93e-05	0.00188	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—JAK2—Crohn's disease	2.89e-05	0.00186	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—DNMT3A—Crohn's disease	2.83e-05	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.8e-05	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—Crohn's disease	2.75e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR9—Crohn's disease	2.73e-05	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—Crohn's disease	2.71e-05	0.00175	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.68e-05	0.00173	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.64e-05	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—UBE2D1—Crohn's disease	2.59e-05	0.00167	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ZFP36L1—Crohn's disease	2.57e-05	0.00165	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.54e-05	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GPR65—Crohn's disease	2.53e-05	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ZFP36L1—Crohn's disease	2.53e-05	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—Crohn's disease	2.52e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—HSPA1B—Crohn's disease	2.51e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—SMAD3—Crohn's disease	2.49e-05	0.0016	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.44e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ACKR2—Crohn's disease	2.43e-05	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	2.39e-05	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.38e-05	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—STAT3—Crohn's disease	2.37e-05	0.00152	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.33e-05	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.33e-05	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MLN—Crohn's disease	2.31e-05	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR6—Crohn's disease	2.29e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.28e-05	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.26e-05	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—UBE2D1—Crohn's disease	2.2e-05	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—DNMT3A—Crohn's disease	2.18e-05	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—DNMT3A—Crohn's disease	2.15e-05	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.14e-05	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TAGAP—Crohn's disease	2.11e-05	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALB—Crohn's disease	2.11e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RBX1—Crohn's disease	2.07e-05	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—Crohn's disease	2.05e-05	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.04e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTGER4—Crohn's disease	2.02e-05	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.98e-05	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—SMAD3—Crohn's disease	1.92e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HSPA1B—Crohn's disease	1.91e-05	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	1.89e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.88e-05	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.86e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SMAD3—Crohn's disease	1.85e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RSPO3—Crohn's disease	1.85e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—Crohn's disease	1.84e-05	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—UBE2D1—Crohn's disease	1.82e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR6—Crohn's disease	1.81e-05	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.77e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RIPK2—Crohn's disease	1.76e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SEL1L—Crohn's disease	1.75e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.74e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL3—Crohn's disease	1.72e-05	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—UBE2D1—Crohn's disease	1.68e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RASGRP1—Crohn's disease	1.66e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—Crohn's disease	1.65e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RBX1—Crohn's disease	1.63e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR9—Crohn's disease	1.6e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTGER4—Crohn's disease	1.59e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—SMAD3—Crohn's disease	1.58e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	1.53e-05	0.000987	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.53e-05	0.000984	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SOCS1—Crohn's disease	1.5e-05	0.000968	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GPR65—Crohn's disease	1.49e-05	0.000957	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—Crohn's disease	1.48e-05	0.000953	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HSPA1B—Crohn's disease	1.47e-05	0.000949	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HSPA1B—Crohn's disease	1.45e-05	0.000934	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—UBE2D1—Crohn's disease	1.43e-05	0.000921	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.43e-05	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RIPK2—Crohn's disease	1.39e-05	0.000894	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL3—Crohn's disease	1.35e-05	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RASGRP1—Crohn's disease	1.31e-05	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.3e-05	0.000839	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMAD3—Crohn's disease	1.3e-05	0.000836	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—UBE2D1—Crohn's disease	1.29e-05	0.000832	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—UBE2D1—Crohn's disease	1.27e-05	0.000819	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.25e-05	0.000803	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TYK2—Crohn's disease	1.21e-05	0.000779	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2RA—Crohn's disease	1.2e-05	0.000774	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SMAD3—Crohn's disease	1.2e-05	0.000772	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SOCS1—Crohn's disease	1.19e-05	0.000764	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—JAK2—Crohn's disease	1.15e-05	0.000743	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD4—Crohn's disease	1.09e-05	0.000704	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—Crohn's disease	1.09e-05	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.06e-05	0.000683	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR6—Crohn's disease	1.06e-05	0.000682	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—Crohn's disease	1.04e-05	0.000669	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMAD3—Crohn's disease	1.02e-05	0.000659	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FADS1—Crohn's disease	1.02e-05	0.000654	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RBX1—Crohn's disease	9.58e-06	0.000617	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX4—Crohn's disease	9.51e-06	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2RA—Crohn's disease	9.49e-06	0.00061	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTGER4—Crohn's disease	9.33e-06	0.0006	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SMAD3—Crohn's disease	9.25e-06	0.000595	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCKR—Crohn's disease	9.19e-06	0.000591	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SMAD3—Crohn's disease	9.11e-06	0.000586	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—Crohn's disease	9.1e-06	0.000585	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TYK2—Crohn's disease	8.47e-06	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—Crohn's disease	8.47e-06	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—UBE2D1—Crohn's disease	8.4e-06	0.000541	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FADS1—Crohn's disease	8.27e-06	0.000532	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	8.23e-06	0.00053	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RIPK2—Crohn's disease	8.15e-06	0.000524	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JAK2—Crohn's disease	8.08e-06	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL3—Crohn's disease	7.95e-06	0.000511	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX4—Crohn's disease	7.74e-06	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RASGRP1—Crohn's disease	7.69e-06	0.000495	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCKR—Crohn's disease	7.48e-06	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—Crohn's disease	7.38e-06	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTMR3—Crohn's disease	7e-06	0.00045	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS1—Crohn's disease	6.96e-06	0.000448	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TYK2—Crohn's disease	6.68e-06	0.00043	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.56e-06	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JAK2—Crohn's disease	6.38e-06	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMAD3—Crohn's disease	6.01e-06	0.000387	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—Crohn's disease	5.93e-06	0.000382	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—Crohn's disease	5.92e-06	0.000381	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—Crohn's disease	5.82e-06	0.000374	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.74e-06	0.00037	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2RA—Crohn's disease	5.57e-06	0.000358	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FADS1—Crohn's disease	5.45e-06	0.000351	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.34e-06	0.000344	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX4—Crohn's disease	5.11e-06	0.000329	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCKR—Crohn's disease	4.93e-06	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—Crohn's disease	4.68e-06	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.67e-06	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—Crohn's disease	4.14e-06	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TYK2—Crohn's disease	3.92e-06	0.000252	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JAK2—Crohn's disease	3.74e-06	0.000241	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—Crohn's disease	3.42e-06	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—Crohn's disease	3.27e-06	0.00021	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—Crohn's disease	2.92e-06	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—Crohn's disease	2.75e-06	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—Crohn's disease	2.56e-06	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—Crohn's disease	2.38e-06	0.000153	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.08e-06	0.000134	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—Crohn's disease	1.92e-06	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—Crohn's disease	1.57e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.37e-06	8.83e-05	CbGpPWpGaD
